Ehrlichiosis and human anaplasmosis;Ehrlichiosis y anaplasmosis humana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 6, 2005, Pages 375-380

  Oteo, José Antonio ^a,b,d   Brouqui, Philippe ^b,c  

^a HOSPITAL SAN PEDRO   (Spain)

^b Grupo de Estudio de Patógenos Especiales de la SEIMC   (Spain)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Hospital de La Rioja   (Spain)

Author keywords

Anaplasma phagocytophilum; Anaplasmosis; Ehrlichiosis; Tick

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; LEVOFLOXACIN; OFLOXACIN;

ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; BLOOD CELL; BLOOD CULTURE; CLINICAL FEATURE; DISEASE ASSOCIATION; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIA EWINGII; EHRLICHIOSIS; FLU LIKE SYNDROME; GENETIC ANALYSIS; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE; LEUKOPENIA; REVIEW; SERODIAGNOSIS; SEROPREVALENCE; THROMBOCYTE; THROMBOCYTOPENIA; TICK BITE;

EID: 22644432598     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076178     Document Type: Article

References (30)

1. Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, Ray SC, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmatacea in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, description of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophilum. Int J Syst Evol Microbiol. 2001;51:2145-65.
2. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect. 2002;8:763-72.
3. Brouqui P, Sanogo YO, Caruso G, Merola F, Raoult D. Candidatus Ehrlichia walkerii: a new Ehrlichia detected in Ixodes ricinus collected from asymptomatic humans in Northern Italy. Ann N Y Acad Sci. 2003;990:134-40.
4. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chafeensis, a new species associated with human ehrlichiosis. J Clin microbiol. 1991;29:2838-42.
5. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocitotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 1994;32:589-95.
6. Buller RS, Arens M, Hmiel SP, Padock CD, Summer W, Rikihisa Y, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 1999;341:148-55.
7. Petrovec M, Lotrick-Furlan S, Zupank TA, Strle F, Brouqui P, Roux V. Human disease in Europe caused by granulocytic ehrlichia species. J Clin Microbiol. 1997;35:1556-9.
8. Oteo JA, Blanco JR. Epidemiological importance of human ehrlichiosis in Europe. Croat J Infect. 2004;24:5-10.
9. Oteo JA, Blanco JR, De Artola V, Ibarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis. 2000;6:430-1.
10. Pérez M, Rikihsa Y, Wen B. Ehrlichia canis like agent isolated from a man in Venezuela: Antigenic and genetic characterization. J Clin Microbiol. 1996;34:2133-9.
11. Oteo JA, Gil H, Barral M, Pérez A, Jiménez S, Blanco JR, et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect. 2001;127:353-8.
12. Portillo A, Santos AS, Santibáñez S, Blanco JR, Ibarra V, Bacellar F, et al. Detección de variantes no patógenas de Anaplasma phagocytophilum en Ixodes ricinus de la península Ibérica. Enferm Infecc Microbiol Clin. 2004;22: 151.
13. Walker DH, Dumler JS. Human monocytic ehrlichiosis and granulocytic ehrlichiosis. Arch Pathol Lab Med. 1997;121:785-91.
14. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR; ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella; European Network for Surveillance of Tick-Borne Diseases. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10:1108-32.
15. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Strle F. Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci. 2003;990:279-84.
16. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First cases of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol Infect Dis. 2001;20:196-8.
17. Remy V, Hansmann Y, De Martino SJ, Christmann D, Brouqui P. Human anaplasmosis presenting as atypical pneumonitis in France. Clin Infect Dis. 2003;37:846-8.
18. Ratnasamy N, Everett ED, Roland WE, MacDonald G, Caldweell CHW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis. 1996;23:314-9.
19. Thomas V, Anguita J, Barthold SW, Fikrig E. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun. 2001;69:3359-71.
20. Lotric-Furlan S, Avsic-Zupanc T, Petrovec M, Nicholson WL, Sumner JW, Childs JE, et al. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol. 2001;8:899-903.
21. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Kurtti TJ, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med. 1996;334:209-15.
22. Brouqui P, Salvo E, Dumler JS, Raoult D. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol. 2000;8:199-202.
23. Guerrero A, Losada I, De Lucas S, Oteo JA. Ehrlichiosis infection prevalence in Spain or cross-reactions. Med Clin (Barc). 2001;116:315.
24. Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn. 1996;1:41-9.
25. Walls JJ, Caturegli P, Bakken JS, Asanovich KM, Dumler JS. Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol. 2000;38:354-6.
26. Massung RF, Slater KG. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. J Clin Microbiol. 2003;41:717-22.
27. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996;275:199-205.
28. Centers for Diseases Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46:46-7.
29. Oteo JA, Blanco JR, Ibarra V. Can we prevent tick-borne transmission disease? Enf Infecc Microbiol Clin. 2001;19:509-13.
30. Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME, Kalantarpour F, Chowdhury I, Wormser GP, et al. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother. 2001;45:786-8.